Type your tag names separated by a space and hit enter

Low-molecular-weight heparins (LMWH) versus unfractionated heparin for venous thromboembolism

Low-molecular-weight heparins (LMWH) versus unfractionated heparin for venous thromboembolism is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Low-molecular-weight heparins (LMWH) versus unfractionated heparin for venous thromboembolism ID - 452143 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452143/all/Low_molecular_weight_heparins__LMWH__versus_unfractionated_heparin_for_venous_thromboembolism PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -